Lipoflex Plus

Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonine, the active ingredient in Lipoflex Plus, is a nutrition supplement presented as a sterile solution for intravenous use. It supports amino‑acid balance in patients requiring parenteral nutrition.

GNH USA supplies Lipoflex Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lipoflex Plus, a parenteral amino‑acid nutrition supplement, is used to address metabolic needs in several clinical situations.

- Post‑operative recovery: helps maintain protein synthesis and tissue repair. - Severe malnutrition: provides essential amino acids for rebuilding lean body mass. - Critical illness/ICU patients: supports nitrogen balance and prevents catabolism.

Lipoflex Plus may be associated with a range of infusion‑related reactions.

Common Side Effects: - Infusion site erythema or pain. - Mild hypernatremia. - Transient increase in blood urea nitrogen. - Slight elevation of serum ammonia. - Temporary headache.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction. - Severe electrolyte imbalance (e.g., hyperkalemia, hypocalcemia). - Metabolic acidosis. - Acute renal dysfunction. - Thrombophlebitis at the infusion site.

When using Lipoflex Plus, clinicians should consider several safety aspects.

- Renal impairment: monitor serum creatinine and nitrogen waste. - Hepatic disease: adjust amino‑acid load and watch for encephalopathy. - Electrolyte disorders: check serum electrolytes before and during infusion. - Pregnancy and lactation: use only if potential benefit justifies risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Lipoflex Plus can interact with other therapies that affect protein or electrolyte balance.

Major Interactions (Avoid): - High‑dose oral protein supplements: risk of hyperammonemia. - Renal replacement therapy: altered clearance of amino acids. - Certain diuretics (e.g., loop diuretics): may exacerbate electrolyte shifts.

Moderate Interactions (Monitor Closely): - Insulin therapy: amino acids may affect glucose control. - Corticosteroids: increased protein catabolism may require dose adjustment. - Concurrent electrolyte solutions: monitor for imbalances.